Landt M, Hortin G L, Smith C H, McClellan A, Scott M G
Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, MO 63110.
Clin Chem. 1994 Apr;40(4):565-70.
We determined the suitability of various heparin salts used for anticoagulation of whole-blood specimens for measurement of ionized calcium (iCa), blood gases, and electrolytes. We were particularly interested in a new heparin product containing both zinc and lithium cations (CNLZ heparin), in which the binding sites with greatest affinity for divalent cations are bound with zinc and low-affinity sites with lithium. In initial experiments Li heparin decreased iCa concentrations 0.07 mmol/L at the lowest heparin concentration (3000 units/L) and progressively lowered them at higher concentrations. Zn heparin initially increased iCa concentrations 0.06 mmol/L but progressively lowered them as the heparin concentration was increased. Li heparin interfered even when present in amounts (9 units per 3-mL syringe) minimally effective in preventing coagulation. Use of CNLZ heparin (36 units per 3-mL syringe; Zn 63-78 g/kg of heparin) largely eliminated interference of heparin in iCa measurements. In studies that included the effects of concentration of heparin through partial filling of syringes, specimens anticoagulated with CNLZ heparin compared well with unheparinized controls in measurements of iCa, blood gases, and electrolytes. Blood gases and iCa results on CNLZ-heparinized specimens from intensive-care-unit patients also compared well with specimens anticoagulated with a preparation of heparin (EB heparin) in which calcium has been added to balance the calcium-binding capacity. However, the presence of calcium in EB heparin significantly increased measured total calcium concentrations, whereas the new CNLZ heparin did not interfere in total calcium determinations.
我们确定了用于全血标本抗凝以测量游离钙(iCa)、血气和电解质的各种肝素盐的适用性。我们特别关注一种同时含有锌和锂阳离子的新型肝素产品(CNLZ肝素),其中对二价阳离子具有最高亲和力的结合位点与锌结合,而低亲和力位点与锂结合。在初始实验中,锂肝素在最低肝素浓度(3000单位/升)时使iCa浓度降低0.07 mmol/L,并在较高浓度时逐渐降低。锌肝素最初使iCa浓度升高0.06 mmol/L,但随着肝素浓度的增加而逐渐降低。即使锂肝素的量(每3毫升注射器9单位)对防止凝血的效果微乎其微,也会产生干扰。使用CNLZ肝素(每3毫升注射器36单位;锌含量为63 - 78微克/千克肝素)在很大程度上消除了肝素对iCa测量的干扰。在包括通过部分填充注射器来研究肝素浓度影响的实验中,用CNLZ肝素抗凝的标本在iCa、血气和电解质测量方面与未用肝素抗凝的对照标本相当。重症监护病房患者的CNLZ肝素抗凝标本的血气和iCa结果与用添加了钙以平衡钙结合能力的肝素制剂(EB肝素)抗凝的标本也相当。然而,EB肝素中钙的存在显著增加了测得的总钙浓度,而新型CNLZ肝素不干扰总钙的测定。